U.S. Markets closed

PDL BioPharma, Inc. (PDLI)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
3.29-0.02 (-0.60%)
At close: 4:00PM EDT

3.29 0.00 (0.00%)
After hours: 4:45PM EDT

People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue244,301590,448581,225
Cost of Revenue4,065--
Gross Profit240,236590,448581,225
Operating Expenses
Research Development3,8203,8203,820
Selling General and Administrative87,68740,06934,914
Non Recurring7,2997,2997,299
Total Operating Expenses110,834--
Operating Income or Loss129,402550,379546,311
Income from Continuing Operations
Total Other Income/Expenses Net-1,7656,818-5,828
Earnings Before Interest and Taxes127,637557,197540,483
Interest Expense18,26727,05939,211
Income Before Tax109,370530,138501,272
Income Tax Expense45,711197,343179,028
Minority Interest4,2804,2804,280
Net Income From Continuing Ops61,253339,245316,101
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income63,606332,795322,244
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares63,606332,795322,244